Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1983 1
1984 4
1998 1
1999 1
2000 4
2001 5
2002 5
2003 4
2004 11
2005 8
2006 11
2007 8
2008 4
2009 1
2010 1
2011 2
2012 1
2013 2
2014 2
2015 5
2016 3
2017 1
2018 4
2019 4
2020 1
2021 5
2022 1
2023 3
2024 3
2025 8
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Pheochromocytoma with abscess.
Inoue R, Hisasue S, Kunishima Y, Masumori N, Itoh N, Tsukamoto T. Inoue R, et al. Among authors: kunishima y. Int J Urol. 2007 Jul;14(7):644-6. doi: 10.1111/j.1442-2042.2007.01790.x. Int J Urol. 2007. PMID: 17645610
[Management of inclined teeth].
Mikami N, Kunishima Y, Inoue N. Mikami N, et al. Among authors: kunishima y. Shikai Tenbo. 1984 Mar;63(3):549-65. Shikai Tenbo. 1984. PMID: 6591478 Japanese. No abstract available.
Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N. Shindo T, et al. Among authors: kunishima y. World J Urol. 2024 May 9;42(1):307. doi: 10.1007/s00345-024-04952-z. World J Urol. 2024. PMID: 38722418
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
Shindo T, Hashimoto K, Takahashi A, Miyamoto S, Kunishima Y, Sato S, Fukuta F, Hiyama Y, Takayanagi A, Kato R, Wanifuchi A, Ueki Y, Okada M, Adachi H, Kobayashi KO, Tanaka T, Masumori N; Sapporo Medical University Urologic Oncology Consortium. Shindo T, et al. Among authors: kunishima y. Anticancer Res. 2024 Mar;44(3):1271-1279. doi: 10.21873/anticanres.16922. Anticancer Res. 2024. PMID: 38423657
113 results